Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam
Launched by INSTITUT PASTEUR · Aug 16, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving care and treatment for patients in Vietnam who are living with both HIV and Hepatitis C (HCV). The study aims to find better ways to provide HCV treatment in remote areas where access to healthcare is limited. One of the challenges is that testing for HCV is often only available in larger cities, making it hard for patients in rural areas to get the help they need. The trial will explore using a simpler blood testing method to monitor HCV levels and make treatment more accessible. It will also look at the availability of affordable medications for HCV treatment, known as direct acting antivirals (DAAs).
To participate in this trial, you need to be at least 18 years old, have a confirmed diagnosis of HIV, and also have HCV. The study will track how well patients respond to treatment, which may involve visiting different healthcare sites for both HIV and HCV care. Participants can expect to receive close monitoring and support throughout their treatment. It's important to note that some patients might have to visit two different clinics for their HIV and HCV care, which could make it more challenging to stick with the treatment plan.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age at enrolment ≥18 years.
- • Documented HIV-1 infection.
- • HCV infection documented by the presence of Anti-HCV antibodies or a positive RDT; if the result was negative but dates from more than 6 months the patient will be tested again.
- • Consent to participate in the study
- Exclusion Criteria:
- • HCV negative patient.
- • Patient not routinely followed for HIV care in the clinical sites participating in the study.
- • Previous treatment by DAA.
- • Patient for whom the health status, according to the medical staff, may interfere with the study or is not compatible with the sampling planned in the study
About Institut Pasteur
Institut Pasteur is a renowned global research organization dedicated to advancing biomedical science and public health. Established in 1887, it has a rich history of groundbreaking contributions to the understanding and prevention of infectious diseases. The institute conducts innovative clinical trials aimed at developing vaccines, diagnostics, and therapeutic strategies to combat a wide range of health threats. With a multidisciplinary approach and a commitment to collaboration, Institut Pasteur plays a pivotal role in translating scientific discoveries into tangible health solutions, thereby enhancing global health security and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vinh, Nghe An, Vietnam
Yên Bái, Yen Bai, Vietnam
Patients applied
Trial Officials
Yoann MADEC, PhD
Principal Investigator
Institut Pasteur
Tuan Anh NGUYEN, PhD
Principal Investigator
National Institute of Hygiene and Epidemiology, Vietnam
Thang Hong PHAM, PhD
Principal Investigator
National Institute of Hygiene and Epidemiology, Vietnam
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials